We used descriptive statistics to characterize the new drugs and biologics and postmarketing commitments. Analyses were performed using R (version 3.2.3; The R Project for Statistical Computing).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.